Use of Ketosis in Modulating Metabolic Pathways in Bipolar Disorder
Use of Ketosis in Modulating Metabolic Pathways in Bipolar Disorder
Recruiting · NCT06373016 · Registry updated 2026-04-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Use of Ketosis in Modulating Metabolic Pathways in Bipolar Disorder | Bipolar Disorder Type 1, Bipolar and Related Disorders, bipolar disorder, mood disorder, psychiatric disorder | Recruiting | Not applicable | 2026-04-15 | NCT06373016 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Massachusetts General Hospital | 758 |
| Mclean Hospital | 54 |
| Stony Brook University | 44 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Laufer Center for Physical and Quantitative Biology , Stony Brook University | Stony Brook | United States | 1 |
| Martinos Center for Biomedical Research, Building 149, 13th Street | Charlestown | United States | 1 |
| McLean Hospital | Belmont | United States | 47 |